... Skip to content
World IP Day 2026 — Recognized Innovator

Ehud
Schwammenthal

  • Co-Founder & Chief Medical Officer
  • Magenta Medical Ltd

 Recognized as the co-founder and named inventor behind Magenta Medical’s percutaneous heart pump platform. A cardiologist and repeat medical device entrepreneur, his clinical and engineering insight helped produce the world’s smallest heart pump, which is now in U.S. clinical trials with FDA Breakthrough Device Designation.

Certificate of Recognition

Top IP Innovator — Mechanical Circulatory Support · 2026

Magenta Patents (last 5 years)
0 +
First Filing
2014
USPTO Art Unit Focus
3792 / 3796
Role
Co-Founder & CMO
Presented by InspireIP

World IP Day Recognition Series · 2026

Magenta patents, last 5 years
0
Filed in 2025 alone
0 +
Recognition category
0 Medical Devices
The Recognition

Making the heart pump small enough to save more lives

On World IP Day 2026, InspireIP recognizes Ehud Schwammenthal, co-founder and chief medical officer of Magenta Medical, for his inventor footprint and clinical leadership at the company.

The recognition is based on Magenta’s patent activity and public patent records where Ehud is named as inventor. His filings cover left-ventricular assist devices, self-expanding impeller systems, blood pump tube designs, drive cable mechanisms, and blood pressure measurement within percutaneous pumps. These patents protect the core of Magenta’s Elevate platform, a miniaturized heart pump that fits an 8-French delivery system and can deliver over 5 liters per minute of blood flow.

Ehud holds an MD and a PhD in cardiovascular physiology from the University of Muenster and trained in cardiology in Germany before completing a research fellowship at Massachusetts General Hospital, Harvard Medical School. Before Magenta, he co-founded Ventor Technologies, which developed a catheter-based aortic valve replacement system and was acquired by Medtronic in 2009. He co-founded Magenta in 2012 alongside mechanical engineer Yosi Tuval to bring the same interventional approach to heart failure.

Percutaneous Heart Pumps
Left Ventricular Assist Devices
Mechanical Circulatory Support
Self-Expanding Impellers
Cardiogenic Shock
High-Risk PCI
Patent Footprint

A portfolio shaped around keeping the heart beating

2012–2014

Prof. Ehud Schwammenthal and Yosi Tuval co-founded Magenta Medical in Kadima, Israel, with a $4M seed round from Pitango Venture Capital. The company files its first patents, with Ehud named as inventor alongside Tuval and the engineering team.

2015–2020

The portfolio grows to 19 filings in 2020 as Magenta advances its Elevate pump through European clinical trials, raises a $15M Series B backed by Abiomed, Pitango, and JAFCO, and secures FDA Breakthrough Device Designation for two indications: high-risk PCI and cardiogenic shock.

2021–2023

The company files 37 patent applications across three years. Magenta initiates its FDA-approved Early Feasibility Study in 2023, enrolling and treating 15 patients. The study meets its objectives, with results presented at the TCT conference in San Francisco.

2024–2025

44 more patents across two years, peaking at 29 filings in 2024. Magenta closes a $105M round led by Novo Holdings, bringing total funding to $183 million. The company prepares to launch its U.S. pivotal study.

Mechanical Circulatory Support

A small-entity company filing like a much larger one

Magenta Medical is classified by the USPTO as a Small Entity, yet its five-year filing volume sits well above what is typical for medical device companies of its size. Much of that activity is concentrated in the mechanical and manufacturing art units that protect percutaneous pump designs, impeller systems, and catheter-based delivery mechanisms.

Patents, last 5 years
Peak year (2024)
Filings
USPTO entity status
Small Entity
Art unit focus
3792 / 3796
"Leading an innovation program is harder than inventing on your own. It means choosing what to file, who to credit, and where to invest, over and over, for years. The leaders we recognize on World IP Day have done that consistently, and built something that compounds."

Sam Zellner

Founder, InspireIP · Inventor · Innovation Leader

About Magenta Medical

Built in Israel, advancing toward FDA approval

Founded in 2012 and headquartered in Kadima, Israel, Magenta Medical develops miniaturized blood pumps for temporary mechanical circulatory support.

Its Elevate percutaneous left ventricular assist device is designed to support patients with acute left ventricular dysfunction, including those undergoing high-risk coronary interventions or experiencing cardiogenic shock.

Elevate fits through an 8-French delivery system, self-expands inside the heart, and delivers flow above 5 liters per minute. It has received FDA Breakthrough Device Designation for two indications and completed a U.S. Early Feasibility Study in 2023.

IP Day 2027

Know an IP innovator who deserves recognition?

Each year we recognize the inventors and IP leaders behind the portfolios that protect what their companies create. That includes founder-inventors whose contributions often go unmarked. Nominate someone for next year’s list.

Subscribe to Trust Center Updates

Subscribe to get notifications about important update to InspireIP's compliance journey.
By signing up for email notifications you agree to the privacy policy.

InspireIP has restricted access for 'System Acquisition and Development Lifecycle Policy'. We need your work email to validate OR request your access to this item.